Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;33(7):1233-1235.
doi: 10.1681/ASN.2022040506. Epub 2022 Jun 21.

Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations

Affiliations
Editorial

Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations

Hans-Joachim Anders et al. J Am Soc Nephrol. 2022 Jul.
No abstract available

Keywords: focal segmental glomerulosclerosis; human genetics; nephrotic syndrome; pathophysiology of kidney disease and progression; proteinuria.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The role of kidney biopsy in the diagnosis and prognosis prediction of podocytopathies. Kidney disease categories keep developing; this offers novel opportunities to overcome the hurdles related to MCD and FSGS, which are not diseases. Although defining a precise molecular diagnosis for these podocytopathies has remained challenging, whole-exome sequencing, together with reverse phenotyping for subtle manifestations of monogenic syndromal disorders and the identification of antinephrin antibodies as a cause for an autoimmune podocytopathy, offer promising possibilities for a definite diagnosis in the majority of patients. Prognosis prediction from histologic lesion patterns benefits from analyzing the biopsy at a high granularity and employing machine-learning tools. The future will be adding other diagnostic tools to predict prognosis (and define treatment) on the basis of identifying the underlying disease-causing podocyte injury.

Comment on

References

    1. Jarcy Z, Liu Q, Smith AR, Hodgin JB, Rosenberg A, Gillespie BW, et al. : Kidney biopsy features most predictive of clinical outcomes in the spectrum of minimal change disease and focal segmental glomerulosclerosis. J Am Soc Nephrol 33: 1411–1426, 2022 - PMC - PubMed
    1. Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. ; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants : Oxford classification of IgA nephropathy 2016: An update from the IgA Nephropathy Classification Working Group. Kidney Int 91: 1014–1021, 2017 - PubMed
    1. Barisoni L, Lafata KJ, Hewitt SM, Madabhushi A, Balis UGJ: Digital pathology and computational image analysis in nephropathology. Nat Rev Nephrol 16: 669–685, 2020 - PMC - PubMed
    1. KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases : Kidney Int Suppl 100: S1–S276, 2021. Available at https://www.kidney-international.org/article/S0085-2538(21)00562-7/fulltext. Accessed May 26, 2021 - PubMed
    1. Kopp JB, Anders HJ, Susztak K, Podestà MA, Remuzzi G, Hildebrandt F, et al. : Podocytopathies. Nat Rev Dis Primers 6: 68, 2020 - PMC - PubMed

LinkOut - more resources